CN Patent

CN101686944A — 熊去氧胆酸的高剂量组合物

Assigned to Disphar International BV · Expires 2010-03-31 · 16y expired

What this patent protects

本发明涉及用于口服给药的包含熊去氧胆酸的高剂量多颗粒药物制剂，以及制备所述组合物的方法。

USPTO Abstract

本发明涉及用于口服给药的包含熊去氧胆酸的高剂量多颗粒药物制剂，以及制备所述组合物的方法。

Drugs covered by this patent

rosuvastatin-calcium (ROSUVASTATIN CALCIUM)

Patent Metadata

Patent number: CN101686944A
Jurisdiction: CN
Classification: —
Expires: 2010-03-31
Drug substance claim: No
Drug product claim: No
Assignee: Disphar International BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.